Cecilia Becattini Selected Research

Cecilia Becattini Research Topics

Disease

70	Hemorrhage 05/2024 - 12/2002
56	Venous Thromboembolism 05/2024 - 07/2003
36	Pulmonary Embolism 03/2024 - 12/2002
35	Neoplasms (Cancer) 05/2024 - 02/2008
24	Atrial Fibrillation 10/2023 - 01/2005
17	Thrombosis (Thrombus) 10/2023 - 01/2005
14	Stroke (Strokes) 10/2023 - 01/2005
11	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 02/2008
8	COVID-19 12/2023 - 01/2021
8	Ischemic Stroke 12/2023 - 03/2012
5	Renal Insufficiency (Renal Failure) 01/2022 - 09/2016
4	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2021
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 05/2021
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2023 - 01/2020
3	Critical Illness (Critically Ill) 01/2023 - 01/2021
3	Thrombocytopenia (Thrombopenia) 05/2022 - 05/2019
3	Shock 11/2020 - 07/2007
3	Embolism (Embolus) 04/2019 - 03/2012
3	Right Ventricular Dysfunction 01/2018 - 11/2013
3	Myocardial Infarction 09/2014 - 03/2010
3	Clinical Deterioration 11/2013 - 10/2008
2	Urogenital Neoplasms 01/2023 - 05/2022
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2016
2	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2021
2	Inflammation (Inflammations) 01/2022 - 07/2020
2	Infections 01/2022 - 07/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Body Weight (Weight, Body) 05/2021 - 01/2020
2	Hematoma 01/2021 - 01/2020
2	Cerebral Hemorrhage 01/2020 - 01/2020
2	Embolic Stroke 01/2019 - 08/2015
2	Syncope (Fainting) 01/2018 - 01/2017
2	Overweight 05/2017 - 09/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 06/2007
2	Acute Coronary Syndrome 05/2008 - 01/2005
1	Leukemia 07/2023
1	Severe Acute Respiratory Syndrome 05/2022
1	Infarction (Infarctions) 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Disease Progression 05/2021
1	Viremia 02/2021
1	Sepsis (Septicemia) 10/2020

Drug/Important Bio-Agent (IBA)

93	AnticoagulantsIBA 03/2024 - 07/2003
21	RivaroxabanIBA 05/2024 - 05/2010
20	Vitamin K FDA Link 12/2023 - 01/2005
16	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 02/2008
16	apixabanIBA 01/2024 - 03/2012
13	Heparin (Liquaemin)FDA LinkGeneric 12/2023 - 12/2002
10	Dalteparin (Dalteparin Sodium)FDA Link 01/2024 - 09/2018
9	Dabigatran FDA Link 02/2020 - 05/2010
8	TroponinIBA 01/2021 - 07/2007
7	Warfarin (Coumadin)FDA LinkGeneric 10/2018 - 02/2008
6	Factor Xa InhibitorsIBA 04/2023 - 01/2016
5	CreatinineIBA 01/2023 - 09/2016
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020 - 03/2012
3	fibrin fragment D (D-dimer)IBA 06/2017 - 02/2008
3	Tenecteplase FDA Link 03/2017 - 03/2010
3	AntithrombinsIBA 06/2012 - 01/2005
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 11/2020
2	edoxabanIBA 07/2020 - 01/2020
2	von Willebrand FactorIBA 07/2020 - 06/2007
2	Factor Xa (Coagulation Factor Xa)IBA 06/2013 - 06/2012
2	Thrombin FDA Link 06/2013 - 06/2012
1	Phospholipid EthersIBA 12/2023
1	LipidsIBA 12/2023
1	G(M3) GangliosideIBA 12/2023
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2022
1	VaccinesIBA 05/2022
1	AntigensIBA 05/2022
1	eltrombopag FDA Link 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Viral RNAIBA 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021

Therapy/Procedure

32	Therapeutics 01/2024 - 07/2003
8	Length of Stay 10/2022 - 05/2008
5	Secondary Prevention 01/2020 - 02/2016
4	Thrombolytic Therapy 01/2020 - 04/2014
3	Duration of Therapy 07/2022 - 07/2003
2	Contraindications 01/2021 - 01/2020
2	Vena Cava Filters (Inferior Vena Cava Filter) 12/2016 - 09/2016
1	Transcatheter Aortic Valve Replacement 10/2023
1	Catheters 05/2021
1	Noninvasive Ventilation 01/2021
1	Fluid Therapy (Oral Rehydration Therapy) 10/2020